InflaRx N.V. (IFRX)
NASDAQ: IFRX · IEX Real-Time Price · USD
1.530
0.00 (0.00%)
Jul 26, 2024, 4:30 PM EDT - Market closed
InflaRx Market Cap
InflaRx has a market cap or net worth of $90.09 million as of July 26, 2024. Its market cap has decreased by -51.28% in one year.
Market Cap
90.09M
Enterprise Value
151.94K
1-Year Change
-51.28%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $90.09M, a decrease of -74.33%. That is a compound annual growth rate of -18.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 90.10M | -6.15% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monogram Orthopaedics | 86.14M |
| Leap Therapeutics | 86.10M |
| Clearside Biomedical | 85.94M |
| BeyondSpring | 85.44M |
| Nutriband | 85.42M |
| Hyperfine | 85.33M |
| Protalix BioTherapeutics | 84.31M |
| Benitec Biopharma | 84.21M |